Bio Essence Corp financial data

Symbol
BIOE on OTC
Location
2955 Main Street, Ste 300, Irvine, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 7.64 % -68.8%
Quick Ratio 6.07 % -5.3%
Debt-to-equity -108 % +46%
Return On Equity 5.19 % -93.1%
Return On Assets -68 % +9.82%
Operating Margin -62.7 % +23.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38M shares 0%
Common Stock, Shares, Outstanding 38M shares 0%
Entity Public Float 26.8M USD
Common Stock, Value, Issued 3.8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 38M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 38M shares +9.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 137K USD +1.57%
Cost of Revenue 41K USD -23.6%
General and Administrative Expense 516K USD -32.8%
Operating Income (Loss) -126K USD +80.9%
Nonoperating Income (Expense) -33.9K USD +96.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -160K USD +90.7%
Income Tax Expense (Benefit) 800 USD 0%
Net Income (Loss) Attributable to Parent -160K USD +89.1%
Earnings Per Share, Basic 0 USD/shares -50%
Earnings Per Share, Diluted 0 USD/shares -50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 28.7K USD -3.61%
Accounts Receivable, after Allowance for Credit Loss, Current 4.97K USD -92.4%
Inventory, Net 143K USD -20.9%
Assets, Current 184K USD -74.2%
Property, Plant and Equipment, Net 3.69K USD -98.5%
Operating Lease, Right-of-Use Asset 1.18M USD +20.8%
Intangible Assets, Net (Excluding Goodwill) 156 USD -60.1%
Other Assets, Noncurrent 274 USD -99.5%
Assets 185K USD -74.2%
Accounts Payable, Current 10.6K USD -67%
Accrued Liabilities, Current 3.3K USD -51.1%
Liabilities, Current 3.23M USD +5.32%
Operating Lease, Liability, Noncurrent 99.7K USD -85.2%
Other Liabilities, Noncurrent 302K USD +438%
Liabilities 3.29M USD -10.1%
Retained Earnings (Accumulated Deficit) -10.6M USD -1.54%
Stockholders' Equity Attributable to Parent -3.1M USD -5.46%
Liabilities and Equity 185K USD -74.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -26.1K USD +84.8%
Net Cash Provided by (Used in) Financing Activities 24.7K USD -85.6%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 38M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 23 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28.7K USD -3.61%
Interest Paid, Excluding Capitalized Interest, Operating Activities 543 USD -88.4%
Deferred Tax Assets, Valuation Allowance 1.33M USD +103%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 699K USD +12.1%
Operating Lease, Liability 1.39M USD
Depreciation 238 USD
Lessee, Operating Lease, Liability, to be Paid 1.56M USD
Property, Plant and Equipment, Gross 56.5K USD 0%
Operating Lease, Liability, Current 1.5M USD +64.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 588K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 571K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 3.2K USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 125K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 400K USD
Deferred Tax Assets, Operating Loss Carryforwards 1.33M USD
Current Income Tax Expense (Benefit) 3.2K USD 0%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 7.48M USD 0%
Amortization of Intangible Assets 58 USD -75.3%
Depreciation, Depletion and Amortization 497 USD -80%
Interest Expense 542 USD -2.17%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%